Arvinas Profit Margin

The latest profit margin for ARVN is 2.94% as of June 2026. That compares with -19.47% in the prior-year period — up 115.1% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Arvinas's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARVN's profit margin moved from -19.47% to 2.94% — a 115.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Arvinas's valuation or profitability profile.

Against Healthcare companies, ARVN currently prints 2.94% for profit margin, while the sector average sits near 14.34%. That is roughly 79.5% below the sector mean. Large gaps often invite a closer look at Arvinas's growth, margins, and balance sheet.

Profit Margin shows how effectively Arvinas converts resources into returns. At 2.94%, ARVN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -19.47% in the prior-year period — up 115.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ARVN's profit margin (2.94%), review year-over-year change from -19.47%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.